Predictors of a clinical high risk status among individuals with a family history of psychosis

Schizophrenia Research

Volumn 147, Issue 2-3, 2013, Pages 281-286

  Stowkowy, Jacqueline ^a   Addington, Jean ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Family history; Prodrome; Psychosis; Risk; Risk factors

Indexed keywords

CANNABIS;

ADULT; AGE; ANXIETY; ARTICLE; CALGARY DEPRESSION SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HIGH RISK; FAMILY HISTORY; FAMILY INTERVIEW FOR GENETICS STUDIES; FEMALE; GENETIC RISK; HUMAN; INTELLIGENCE QUOTIENT; MALE; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SELF REPORT; SOCIAL ASPECT; STRUCTURED CLINICAL INTERVIEW FOR DSM-IV DISORDERS; STRUCTURED INTERVIEW; STRUCTURED INTERVIEW FOR PRODROMAL SYNDROMES;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; DISCRIMINATION (PSYCHOLOGY); FAMILY HEALTH; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; YOUNG ADULT;

EID: 84878958748     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.03.030     Document Type: Article

References (59)

1. AbdelMalik P., Husted J., Chow E.W.C., Bassett A.S. Childhood head injury and expression of schizophrenia in multiply affected families. Arch. Gen. Psychiatry 2003, 60:231-236.
2. Addington J., Barbato M. The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis. Epidemiol. Psychiatr. Sci. 2012, 21(4):335-342.
3. Addington J., Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annu. Rev. Clin. Psychol. 2012, 8:269-289.
4. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry 1993, 163:39-44.
5. Addington J., Cadenhead K., Cornblatt B., Mathalon D., McGlashan T., Perkins D., Seidman L., Tsuang M.T., Walker E.F., Woods S.W., Addington J.A., Cannon T.D. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr. Res. 2012, 142:77-82.
6. Arseneault L., Cannon M., Poulton R., Murray R.M., Caspi A., Moffitt T.E. Cannabis use in adolecence and risk for adult psychosis: longitudinal prospective study. Br. Med. J. 2002, 325:1195-1199.
7. Arseneault L., Cannon M., Fisher H.L., Polanczyk G., Moffitt T.E., Caspi A. Childhood trauma and children's emerging psychotic symptoms: a genetically sensitive longitudinal cohort study. Am. J. Psychiatry 2011, 168:65-72.
8. Bendall S., Alvarez-Jimenez M., Nelson B., McGorry P. Childhood trauma and psychosis: new perspectives on aetiology and treatment. Early Interv. Psychiatry 2013, 7:1-4.
9. Cannon T., Mednick S. The schizophrenia high-risk project in Copenhagen: three decades of progress. Acta Psychiatr. Scand. Suppl. 1993, 370:33-47.
10. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 2002, 159(7):1080-1092.
11. Cannon M., Tarrant C.J., Huttunen J., Jones P. Child development and later schizophrenia: evidence from genetic high risk and birth cohort studies. The Epidemiology of Schizophrenia 2003, 100-122. Cambridge University Press, New York. R. Murray, P. Jones, E. Susser, J. van Os, M. Cannon (Eds.).
12. Cannon-Spoor H., Potkin S., Wyatt R. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8:470-484.
13. Casadio P., Fernandes C., Murray R., Di F.M. Cannabis use in young people: the risk for schizophrenia. Neurosci. Biobehav. Rev. 2011, 35:1779-1787.
14. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
15. Cornblatt B., Neindam T., Auther A., Smith C., Johnson J.C.T. Validation of two new measures of functional outcome in the schizophrenia prodrome. Schizophr. Bull. 2007, 33:688.
16. Cougnard A., Marcelis M., Myin-Germeys I., de G.R., Vollebergh W., Krabbendam L., Lieb R., Wittchen H.U., Henquet C., Spauwen J., van O.J. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol. Med. 2007, 37:513-527.
17. de la Serna E., Baeza I., Andres S., Puig O., Sanchez-Guistau V., Romero S., Bernardo M., Moreno D., Noguera A., Castro-Fornieles J. Comparison between young siblings and offspring of subjects with schizophrenia: clinical and neuropsychological characteristics. Schizophr. Res. 2011, 131:35-42.
18. Dickson H., Laurens K.R., Cullen A.E., Hodgins S. Meta-analyses of cognitive and motor function in youth aged 16years and younger who subsequently develop schizophrenia. Psychol. Med. 2012, 42(4):743-755.
19. Dragt S., Nieman D.H., Schultze-Lutter F., van der Meer F., Becker H., de Haan L., Dingemans P.M., Birchwood M., Patterson P., Salokangas R.K., Heinimaa M., Heinz A., Juckel G., Graf von Reventlow H., French P., Stevens H., Ruhrmann S., Klosterkötter J., Linszen D.H., EPOS group Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr. Scand. 2012, 125(1):45-53.
20. Drake R.E., Mueser K., McHugo G. Clinical rating scales. Outcomes Assessment in Clinical Practice 1996, 113-116. Williams and Wilkins, Baltimore. L. Sederer, B. Dickey (Eds.).
21. Endicott J., Spitzer R., Fleiss J., Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbances. Arch. Gen. Psychiatry 1976, 33:766-771.
22. Erlenmeyer-Kimling L., Rock D., Roberts S.A., et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am. J. Psychiatry 2000, 157:1416-1422.
23. First M., Spitzer R.L., Gibbon M., Williams B., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition 1995, Biometrics Research Department, New York State Psychiatric Institute, New York, New York.
24. Fish B. Involvement of the central nervous system in infants with schizophrenia. Arch. Neurol. 1960, 2:115-121.
25. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 2012, 69(3):220-229.
26. Galvez-Buccollini J., Proal A., Tomaselli V., Trachtenberg M., Coconcea C., Chun J., Manschreck T., Fleming J., DeLisi L. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr. Res. 2012, 139(1-3):157-160.
27. GROUP Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch. Gen. Psychiatry 2010, 68(2):138-147.
28. Harley M., Kelleher I., Clarke M., Lynch F., Arseneault L., Connor D., Fitzpatrick C., Cannon M. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol. Med. 2009, 1-8.
29. Heins M., Simons C., Lataster T., Pfeifer S., Versmissen D., Lardinois M., Marcelis M., Delespaul P., Krabbendam L., van Os J., Myin-Germeys I., for the GROUP project Childhood trauma and psychosis: a case-control and case-sibling comparison across different levels of genetic liability, psychopathology, and type of trauma. Am. J. Psychiatry 2011, 168(12):1286-1294.
30. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005, 330:11.
31. Henquet C., Di F.M., Morrison P., Kuepper R., Murray R.M. Gene-environment interplay between cannabis and psychosis. Schizophr. Bull. 2008, 34:1111-1121.
32. Houston J.E., Murphy J., Adamson G., Stringer M., Shevlin M. Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the national comorbidity survey. Schizophr. Bull. 2008, 34:580-585.
33. Janssen I., Hanssen M., Bak M., Bijl R.V., de Graaf R., Vollebergh W., McKenzie K., van Os J. Discrimination and delusional ideation. Br. J. Psychiatry 2003, 182:71-76.
34. Janssen I., Krabbendam L., Bak M., Hanssen M., Vollebergh W., de Graaf R., van Os J. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr. Scand. 2004, 109:38-45.
35. Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br. J. Psychiatry 2005, 186:18-25.
36. Karlsen S., Nazroo J.Y., McKenzie K., Bhui K., Weich S. Racism, psychosis and common mental disorder among ethnic minority groups in England. Psychol. Med. 2005, 35:1795-1803.
37. Kelly B.D., O'Callaghan E., Waddingtion J., Feeney L., Browne S., Scully P., Clarke M., Quinn J.F., McTigue O., Morgan M.G., Kinsella A., Larkin C. Schizophrenia and the city: a review of the literature and prospective study of psychosis and urbanicity in Ireland. Schizophr. Res. 2010, 11(1):75-89.
38. Keshavan M., Montrose D.M., Rajarethinam R., Diwadkar V.A., Prasad K.M., Sweeney J.A. Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr. Res. 2008, 103:114-120.
39. Konings M., Henquet C., Maharajh H.D., Hutchinson G., van O.J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr. Scand. 2008, 118:209-213.
40. Konings M., Stefanis N., Kuepper R., de Graaf R., ten Have M., van Os J., Bakoula C., Henquet C. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergystically impact on psychosis risk. Psychol. Med. 2012, 42(1):149-159.
41. Krabbendam L., van Os J. Schizophrenia and urbanicity: a major environmental influence-conditional on genetic risk. Schizophr. Bull. 2005, 31:795-799.
42. Kuepper R., van Os J., Lieb R., Wittchen H.U., Henquet C. Do cannabis use and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study. Psychol. Med. 2011, 41(10):2121-2129.
43. Matheson S., Shepard A., Laurens K., Carr V. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr. Res. 2011, 133:133-142.
44. Maxwell M.E. FIGS. Clinical Neurogenetics Branch, Intramural Research Program 1996, NIMH, Bethesda Maryland.
45. McGlashan T., Walsh B.C., Woods S.W. The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-up 2010, Oxford University Press, New York, New York.
46. Mednick S.A., Parnas J., Schulsinger F. The Copenhagen High-Risk Project, 1962-86. Schizophr. Bull. 1987, 13:485-495.
47. Miller B., Suvisaari J., Miettunen J., Jarvelin M.R., Haukka J., Tanskanen A., Lonnqvist J., Isohannit M., Kirkpatrick B. Advanced paternal age and parental history of schizophrenia. Schizophr. Res. 2011, 133(1-3):125-132.
48. Mirsky A.F., Silberman E.K., Latz A., Nagler S. Adult outcomes of high-risk children: differential effects of town and kibbutz rearing. Schizophr. Bull. 1985, 11:150-154.
49. Nagler S., Marcus J., Sohlberg S.C., Lifshitz M., Silberman E.K. Clinical observation of high-risk children. Schizophr. Bull. 1985, 11:107-111.
50. Olivares J., Garcia-Lopez L.J., Hidalgo M.D. The Social Phobia Scale and the Social Interaction Anxiety Scale: factor structure and reliability in a Spanish speaking population. J. Psychoeduc. Assess. 2001, 19:69-80.
51. Reichenberg A., Weiser M., Caspi A., Knobler H.Y., Lubin G., Harvey P.D., Rabinowitz J., Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J. Clin. Exp. Neuropsychol. 2006, 28:193-207.
52. Scala S., Lasalvia A., Cristofalo D., Bonetto C., Ruggeri M. Neurocognitive profile and its association with psychopathology in first degree relatives of patients with schizophrenia. A case control study. Psychiatry Res. 2012, 200(2-3):137-143.
53. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99:1333-1341.
54. Tarbox S.I., Pogue-Geile M.F. Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol. Bull. 2008, 134(4):561-583.
55. Torrey E.F., Bartko J.J., Yolken R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 2012, 38(3):642-647.
56. van Os J., Pedersen C.B., Mortensen P.B. Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. Am. J. Psychiatry 2004, 161:2312-2314.
57. van Os J., Rutten B.P., Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull. 2008, 34:1066-1082.
58. Veling W., Susser E. Migration and psychotic disorders. Expert. Rev. Neurother. 2011, 11(1):65-75.
59. Wechsler D. Wechsler Memory Scale Revised 1987, The Psychological Corporation, New York.